{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:38:08Z","timestamp":1793151488794,"version":"4.5.0"},"reference-count":233,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Systemic juvenile idiopathic arthritis (sJIA) and its complication, macrophage activation syndrome (sJIA-MAS), are rare but sometimes very serious or even critical diseases of childhood that can occasionally be characterized by nonspecific clinical signs and symptoms at onset\u2014such as non-remitting high fever, headache, rash, or arthralgia\u2014and are biologically accompanied by an increase in acute-phase reactants. For a correct positive diagnosis, it is necessary to rule out bacterial or viral infections, neoplasia, and other immune-mediated inflammatory diseases. Delays in diagnosis will result in late initiation of targeted therapy. A set of biomarkers is useful to distinguish sJIA or sJIA-MAS from similar clinical entities, especially when arthritis is absent. Biomarkers should be accessible to many patients, with convenient production and acquisition prices for pediatric medical laboratories, as well as being easy to determine, having high sensitivity and specificity, and correlating with pathophysiological disease pathways. The aim of this review was to identify the newest and most powerful biomarkers and their synergistic interaction for easy and accurate recognition of sJIA and sJIA-MAS, so as to immediately guide clinicians in correct diagnosis and in predicting disease outcomes, the response to treatment, and the risk of relapses. Biomarkers constitute an exciting field of research, especially due to the heterogeneous nature of cytokine storm syndromes (CSSs) in the COVID era. They must be selected with utmost care\u2014a fact supported by the increasingly improved genetic and pathophysiological comprehension of sJIA, but also of CSS\u2014so that new classification systems may soon be developed to define homogeneous groups of patients, although each with a distinct disease.<\/jats:p>","DOI":"10.3390\/ijms232112757","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T04:40:36Z","timestamp":1666586436000},"page":"12757","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8067-5184","authenticated-orcid":false,"given":"Laura Marinela","family":"Ailioaie","sequence":"first","affiliation":[{"name":"Department of Medical Physics, Alexandru Ioan Cuza University, 11 Carol I Boulevard, 700506 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Ailioaie","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Alexandru Ioan Cuza University, 11 Carol I Boulevard, 700506 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6287-0130","authenticated-orcid":false,"given":"Gerhard","family":"Litscher","sequence":"additional","affiliation":[{"name":"Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine, Research Unit for Complementary and Integrative Laser Medicine, Traditional Chinese Medicine (TCM) Research Center Graz, Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Auenbruggerplatz 39, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2014.212","article-title":"Management of juvenile idiopathic arthritis: Hitting the target","volume":"11","author":"Hinze","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_2","first-page":"819","article-title":"Treating juvenile idiopathic arthritis to target: Recommendations of an international task force","volume":"77","author":"Ravelli","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ailioaie, L.M., and Litscher, G. (2020). Molecular and Cellular Mechanisms of Arthritis in Children and Adults: New Perspectives on Applied Photobiomodulation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186565"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/annrheumdis-2014-207164","article-title":"The risk and nature of flares in juvenile idiopathic arthritis: Results from the ReACCh-Out cohort","volume":"75","author":"Guzman","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/acr.24129","article-title":"Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers","volume":"73","author":"Horton","year":"2021","journal-title":"Arthritis Care Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2021-222029","article-title":"Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: Results from the PREVENT-JIA trial","volume":"81","author":"Gerss","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","article-title":"Systemic juvenile idiopathic arthritis","volume":"65","author":"Lee","year":"2018","journal-title":"Pediatr Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/1756-185X.13649","article-title":"Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience","volume":"22","author":"Barut","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/art.40865","article-title":"Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study","volume":"71","author":"Swart","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_10","unstructured":"Newswise (2022, July 10). The American College of Rheumatology Releases Two Updated Guidelines for Treatment of Juvenile Idiopathic Arthritis. Available online: https:\/\/www.newswise.com\/articles\/the-american-college-of-rheumatology-releases-two-updated-guidelines-for-treatment-of-juvenile-idiopathic-arthritis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ailioaie, L.M., Ailioaie, C., and Litscher, G. (2022). Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084268"},{"key":"ref_12","first-page":"459","article-title":"The incidence of macrophage activation syndrome in children with rheumatic disorders","volume":"63","author":"Moradinejad","year":"2011","journal-title":"Minerva Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: Diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Cron, R.Q., and Behrens, E.M. (2019). Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis. Cytokine Storm Syndrome, Springer Nature Switzerland AG. [1st ed.].","DOI":"10.1007\/978-3-030-22094-5"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/rheumatology\/keab948","article-title":"It is about time: The first validated biomarker for early diagnosis of systemic juvenile idiopathic arthritis","volume":"61","author":"Pardeo","year":"2021","journal-title":"Rheumatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1093\/rheumatology\/keab729","article-title":"MRP8\/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever","volume":"61","author":"Park","year":"2022","journal-title":"Rheumatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/art.10882","article-title":"Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis","volume":"48","author":"Meazza","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3899\/jrheum.100655","article-title":"Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis","volume":"38","author":"Yanagimachi","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1073\/pnas.1520779112","article-title":"International Childhood Arthritis Genetics (INCHARGE) Consortium. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis","volume":"112","author":"Ombrello","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.autrev.2017.10.007","article-title":"HLA-DRB1 alleles and juvenile idiopathic arthritis: Diagnostic clues emerging from a meta-analysis","volume":"16","author":"Capittini","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.40498","article-title":"IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis","volume":"70","author":"Arthur","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hou, X., Qu, H., Zhang, S., Qi, X., Hakonarson, H., Xia, Q., and Li, J. (2020). The Multi-Omics Architecture of Juvenile Idiopathic Arthritis. Cells, 9.","DOI":"10.3390\/cells9102301"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"957569","DOI":"10.1155\/2021\/9957569","article-title":"Application of Weighted Gene Coexpression Network Analysis to Identify Key Modules and Hub Genes in Systemic Juvenile Idiopathic Arthritis","volume":"2021","author":"Zhou","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"681526","DOI":"10.3389\/fmolb.2021.681526","article-title":"Identification of Key Biomarkers and Immune Infiltration in Systemic Juvenile Idiopathic Arthritis by Integrated Bioinformatic Analysis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_29","first-page":"247","article-title":"Altered molecular pathways and prognostic markers in active systemic juvenile idiopathic arthritis: Integrated bioinformatic analysis","volume":"22","author":"Ren","year":"2022","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/17534259211001512","article-title":"Human NK cells: From development to effector functions","volume":"27","year":"2021","journal-title":"Innate Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","article-title":"Innate lymphoid cells: Emerging insights in development, lineage relationships, and function","volume":"30","author":"Spits","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate Lymphoid Cells: 10 Years On","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fimmu.2016.00104","article-title":"ILC1s in Tissue Inflammation and Infection","volume":"7","author":"Fuchs","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.20131560","article-title":"T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow","volume":"211","author":"Daussy","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e01659","DOI":"10.7554\/eLife.01659","article-title":"Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells","volume":"3","author":"Sojka","year":"2014","journal-title":"eLife"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/ped.13679","article-title":"Transient Natural Killer Cell Dysfunction Associated with Interleukin-18 Overproduction in Systemic Juvenile Idiopathic Arthritis","volume":"60","author":"Takakura","year":"2018","journal-title":"Pediatr. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2014.05.005","article-title":"Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis","volume":"26","author":"Avau","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/25785826.2021.1912893","article-title":"Macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"44","author":"Shimizu","year":"2021","journal-title":"Immunol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mpd.2003.110","article-title":"Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"142","author":"Grom","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Vastert","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/pai.12130","article-title":"Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis","volume":"24","author":"Zhou","year":"2013","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.39933","article-title":"Inflammatory Gene Expression Profile and Defective Interferon-\u03b3 and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients","volume":"69","author":"Put","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/acr2.11426","article-title":"Impaired Interleukin-18 Signaling in Natural Killer Cells From Patients With Systemic Juvenile Idiopathic Arthritis","volume":"4","author":"Ohya","year":"2022","journal-title":"ACR Open Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3389\/fimmu.2017.01958","article-title":"M1 and M2 monocytes in rheumatoid arthritis: A contribution of imbalance of M1\/M2 monocytes to osteoclastogenesis","volume":"8","author":"Fukui","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s40744-021-00385-x","article-title":"Significance of Macrophage Subtypes in the Peripheral Blood of Children with Systemic Juvenile Idiopathic Arthritis","volume":"8","author":"Feng","year":"2021","journal-title":"Rheumatol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.actbio.2019.02.048","article-title":"Material stiffness influences the polarization state, function and migration mode of macrophages","volume":"89","author":"Sridharan","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/cr.2010.52","article-title":"Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages","volume":"20","author":"Wang","year":"2010","journal-title":"Cell Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","article-title":"M2b macrophage polarization and its roles in diseases","volume":"106","author":"Wang","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jaci.2020.02.034","article-title":"CD163 expression defines specific, IRF8-dependent, immune-modulatory macrophages in the bone marrow","volume":"146","author":"Daber","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.4049\/jimmunol.1800765","article-title":"A Multiparameter Flow Cytometry Analysis Panel to Assess CD163 mRNA and Protein in Monocyte and Macrophage Populations in Hyperinflammatory Diseases","volume":"202","author":"Thornton","year":"2019","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.it.2019.04.012","article-title":"Neutrophil diversity in health and disease","volume":"40","author":"Fridlender","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Fousert, E., Toes, R., and Desai, J. (2020). Neutrophil extracellular traps (NETs) take the central stage in driving autoimmune responses. Cells, 9.","DOI":"10.3390\/cells9040915"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41577-019-0141-8","article-title":"Heterogeneity of neutrophils","volume":"19","author":"Ng","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-016-1069-z","article-title":"Review of biomarkers in systemic juvenile idiopathic arthritis: Helpful tools or just playing tricks?","volume":"18","author":"Gohar","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.38615","article-title":"Review: Is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?","volume":"66","author":"Nigrovic","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.40442","article-title":"Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients with Systemic-Onset Juvenile Idiopathic Arthritis","volume":"70","author":"Tak","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.3389\/fimmu.2018.02995","article-title":"Neutrophils from Children with Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease","volume":"9","author":"Brown","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"766620","DOI":"10.3389\/fimmu.2021.766620","article-title":"Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis","volume":"12","author":"Metzemaekers","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_62","first-page":"74","article-title":"The role of low-density granulocytes and NETosis in the pathogenesis of adult-onset Still\u2019s Disease","volume":"37","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"583513","DOI":"10.3389\/fimmu.2020.583513","article-title":"Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still\u2019s Disease","volume":"11","author":"Jung","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kim, J.-W., Ahn, M.H., Jung, J.Y., Suh, C.H., and Kim, H.A. (2021). An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222313038"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","article-title":"Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"2","author":"Ravelli","year":"2016","journal-title":"RMD Open"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The Immunology of Macrophage Activation Syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_67","unstructured":"De Matteis, A., Pires Marafon, D., Caiello, I., Pardeo, M., Marucci, G., Sacco, E., Prencipe, G., De Benedetti, F., and Bracaglia, C. (2020). Traditional Laboratory Parameters and New Biomarkers in Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis [abstract]. Arthritis Rheumatol., 72, Available online: https:\/\/acrabstracts.org\/abstract\/traditional-laboratory-parameters-and-new-biomarkers-in-macrophage-activation-syndrome-and-secondary-hemophagocytic-lymphohistiocytosis\/."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.revmed.2019.06.001","article-title":"Le temps est venu de r\u00e9concilier l\u2019arthrite juv\u00e9nile idiopathique syst\u00e9mique et la maladie de Still de l\u2019adulte [It is time to reconcile systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease]","volume":"40","author":"Jamilloux","year":"2019","journal-title":"Rev. Med. Interne"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_70","first-page":"229","article-title":"Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis. Best practice & research","volume":"28","author":"Vastert","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/art.22644","article-title":"Specific gene expression profiles in systemic juvenile idiopathic arthritis","volume":"56","author":"Ogilvie","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"Fall","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"vi9","DOI":"10.1093\/rheumatology\/kez350","article-title":"Anakinra in children and adults with Still\u2019s disease","volume":"58","author":"Vastert","year":"2019","journal-title":"Rheumatology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/annrheumdis-2018-213150","article-title":"Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: Results from the 5-year long-term extension of the phase III pivotal trials","volume":"77","author":"Ruperto","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1002\/pmic.201000298","article-title":"Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications","volume":"10","author":"Ling","year":"2010","journal-title":"Proteomics"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.06.017","article-title":"The interleukin (IL)-1 cytokine family\u2014Balance between agonists and antagonists in inflammatory diseases","volume":"66","author":"Palomo","year":"2015","journal-title":"Cytokine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41232-019-0101-5","article-title":"The role of interleukin-1 in general pathology","volume":"39","author":"Kaneko","year":"2019","journal-title":"Inflamm. Regen."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Quartier, P. (2022). Systemic Juvenile Idiopathic Arthritis\/Pediatric Still\u2019s Disease, a Syndrome but Several Clinical Forms: Recent Therapeutic Approaches. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051357"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3899\/jrheum.180331","article-title":"Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis","volume":"46","author":"Saccomanno","year":"2019","journal-title":"J. Rheumatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12969-021-00510-8","article-title":"Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis\u2014Data from the German AID-registry","volume":"19","author":"Lainka","year":"2021","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/art.27485","article-title":"Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis","volume":"62","author":"Wilson","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: Some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.20050640","article-title":"Blocking IL-1 in systemic inflammation","volume":"201","author":"Dinarello","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/acr2.11135","article-title":"Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome","volume":"2","author":"Monteagudo","year":"2020","journal-title":"ACR Open Rheumatol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Wu, C.-Y., Yang, H.-Y., Huang, J.-L., and Lai, J.-H. (2021). Signals and Mechanisms Regulating Monocyte and Macrophage Activation in the Pathogenesis of Juvenile Idiopathic Arthritis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157960"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-018-0224-2","article-title":"Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany","volume":"16","author":"Hinze","year":"2018","journal-title":"Pediatr. Rheumatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/DDDT.S114532","article-title":"The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: Current status and future perspectives","volume":"12","author":"Toplak","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2020.00211","article-title":"NLRP3 Inflammasome-A Key Player in Antiviral Responses","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/art.40099","article-title":"Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by \u03b3\/\u03b4 T Cells in Systemic Juvenile Idiopathic Arthritis","volume":"69","author":"Kessel","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/art.41436","article-title":"Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study","volume":"72","author":"Brunner","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"894846","DOI":"10.3389\/fped.2022.894846","article-title":"Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis","volume":"10","author":"Kostik","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5114\/ceji.2019.87066","article-title":"Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab","volume":"44","author":"Vilaiyuk","year":"2019","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis","volume":"34","author":"Massa","year":"1991","journal-title":"Arthritis Rheum."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s100670170100","article-title":"Cytokine levels in serum of patients with juvenile rheumatoid arthritis","volume":"20","author":"Yilmaz","year":"2001","journal-title":"Clin. Rheumatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: A cross-sectional study","volume":"66","author":"Hoppenreijs","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-016-1212-x","article-title":"Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy","volume":"19","author":"Brachat","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/14397595.2019.1574697","article-title":"Interleukin-6 in juvenile idiopathic arthritis","volume":"29","author":"Akioka","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.23277","article-title":"Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Care Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"923496","DOI":"10.1155\/2014\/923496","article-title":"Intravenous laser blood irradiation and tocilizumab in a patient with juvenile arthritis","volume":"2014","author":"Chiran","year":"2014","journal-title":"Case Rep. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12969-018-0236-y","article-title":"IL-6 blockade in systemic juvenile idiopathic arthritis\u2014Achievement of inactive disease and remission (data from the German AID-registry)","volume":"16","author":"Bielak","year":"2018","journal-title":"Pediatr. Rheumatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12969-020-0399-1","article-title":"Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"18","author":"Shimizu","year":"2020","journal-title":"Pediatr. Rheumatol"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12969-021-00660-9","article-title":"Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: A single-center study","volume":"19","author":"Qu","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"Barrat","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/wound.2019.1032","article-title":"The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis","volume":"9","author":"Steen","year":"2020","journal-title":"Adv. Wound Care"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.4049\/jimmunol.1800468","article-title":"Insufficient IL-10 Production as a Mechanism Underlying the Pathogenesis of Systemic Juvenile Idiopathic Arthritis","volume":"201","author":"Imbrechts","year":"2018","journal-title":"J. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6650928","DOI":"10.1155\/2021\/6650928","article-title":"The Association of Serum IL-10 Levels with the Disease Activity in Systemic-Onset Juvenile Idiopathic Arthritis Patients","volume":"2021","author":"Peng","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","article-title":"Interleukin-18, more than a Th1 cytokine","volume":"25","author":"Novick","year":"2013","journal-title":"Semin. Immunol."},{"key":"ref_110","first-page":"823","article-title":"Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis","volume":"34","author":"Lotito","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e5958","DOI":"10.1590\/1414-431x20165958","article-title":"Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases","volume":"50","author":"Xia","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: Biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Kudela, H., Drynda, S., Lux, A., Horneff, G., and Kekow, J. (2019). Comparative study of Interleukin-18 (IL-18) serum levels in adult-onset Still\u2019s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity. BMC Rheumatol., 3.","DOI":"10.1186\/s41927-019-0053-z"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/kez282","article-title":"IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cei.13543","article-title":"The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome\u2014A systematic review","volume":"203","author":"Krei","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/rheumatology\/keaa634","article-title":"Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis","volume":"60","author":"Mizuta","year":"2021","journal-title":"Rheumatology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","volume":"131","author":"Palomo","year":"2018","journal-title":"Blood"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Girard-Guyonvarc\u2019h, C., Harel, M., and Gabay, C. (2022). The Role of Interleukin 18\/Interleukin 18-Binding Protein in Adult-Onset Still\u2019s Disease and Systemic Juvenile Idiopathic Arthritis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020430"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/rheumatology\/keab342","article-title":"The IL-18\/IFN-\u03b3 axis in systemic JIA and MAS\u2014New answers, more questions","volume":"60","author":"Schulert","year":"2021","journal-title":"Rheumatology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"101280","DOI":"10.1016\/j.smim.2019.05.002","article-title":"IFN-\u03b3: A cytokine at the right time, is in the right place","volume":"43","author":"Burke","year":"2019","journal-title":"Semin. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e28900","DOI":"10.1002\/pbc.28900","article-title":"The role of interferon-gamma and its signaling pathway in pediatric hematological disorders","volume":"68","author":"Merli","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s40778-018-0139-3","article-title":"The Role of Interferon-Gamma in Hematopoietic Stem Cell Development, Homeostasis, and Disease","volume":"4","author":"King","year":"2018","journal-title":"Curr. Stem Cell Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"608492","DOI":"10.3389\/fimmu.2020.608492","article-title":"Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL)","volume":"11","author":"Merli","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17512433.2021.1901576","article-title":"Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis","volume":"14","author":"Garonzi","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: Tipping the balance between interleukin-18 and interferon-\u03b3","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-\u03b3 and interferon-\u03b3-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_130","unstructured":"Bracaglia, C., Pires Marafon, D., Caiello, I., de Graaf, K., Ballabio, M., Ferlin, W., Dav\u00ec, S., Schulert, G., Ravelli, A., and Grom, A.A. (2017). Biomarkers for the Diagnosis and the Identification of Risk of Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA) [abstract]. Arthritis Rheumatol., 69, Available online: https:\/\/acrabstracts.org\/abstract\/biomarkers-for-the-diagnosis-and-the-identification-of-risk-of-macrophage-activation-syndrome-mas-in-systemic-juvenile-idiopathic-arthritis-sjia\/."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpeds.2021.02.008","article-title":"Sudden Hypotension and Increased Serum Interferon-\u03b3 and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis","volume":"235","author":"Guo","year":"2021","journal-title":"J. Pediatr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic Messengers: Tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_133","first-page":"1","article-title":"Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg","volume":"7","author":"Crayne","year":"2019","journal-title":"Eur. J. Rheumatol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Jang, D.I., Lee, A.H., Shin, H.Y., Song, H.R., Park, J.H., Kang, T.B., Lee, S.R., and Yang, S.H. (2021). The Role of Tumor Necrosis Factor Alpha (TNF-\u03b1) in Autoimmune Disease and Current TNF-\u03b1 Inhibitors in Therapeutics. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052719"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1546-0096-12-28","article-title":"Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course","volume":"12","author":"Hinze","year":"2014","journal-title":"Pediatr. Rheumatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.13026","article-title":"Characteristic elevation of soluble TNF receptor II: I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis","volume":"191","author":"Shimizu","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41390-020-0843-4","article-title":"Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy","volume":"88","author":"Irabu","year":"2020","journal-title":"Pediatr. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/rheumatology\/keaa299","article-title":"Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children","volume":"60","author":"Mizuta","year":"2021","journal-title":"Rheumatology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1399-302X.2005.00232.x","article-title":"Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases","volume":"20","author":"Silva","year":"2005","journal-title":"Oral Microbiol. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2004-07-2534","article-title":"Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration","volume":"105","author":"Kwak","year":"2005","journal-title":"Blood"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.yexcr.2011.01.005","article-title":"Chemokines in health and disease","volume":"317","author":"Raman","year":"2011","journal-title":"Exp. Cell Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3389\/fimmu.2018.01930","article-title":"Chemokine-Induced Macrophage Polarization in Inflammatory Conditions","volume":"9","author":"Ruytinx","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"108252","DOI":"10.1016\/j.clim.2019.108252","article-title":"Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"208","author":"Takakura","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/s41598-021-82167-7","article-title":"Inhibition of the CXCL9-CXCR3 axis suppresses the progression of experimental apical periodontitis by blocking macrophage migration and activation","volume":"11","author":"Hasegawa","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2019.03.018","article-title":"Clinical Significance of Serum CXCL9 Levels as a Biomarker for Systemic Juvenile Idiopathic Arthritis Associated Macrophage Activation Syndrome","volume":"119","author":"Mizuta","year":"2019","journal-title":"Cytokine"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1093\/rheumatology\/keab113","article-title":"A dysregulated interleukin-18-interferon-\u03b3-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis","volume":"60","author":"Hinze","year":"2021","journal-title":"Rheumatology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/1756-185X.12196","article-title":"Soluble CD25 in serum: A potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis","volume":"17","author":"Reddy","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cyto.2018.05.017","article-title":"Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis","volume":"110","author":"Sakumura","year":"2018","journal-title":"Cytokine"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/art.41640","article-title":"Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis","volume":"73","author":"Verweyen","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_152","first-page":"220","article-title":"Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases","volume":"78","author":"Dik","year":"2020","journal-title":"Neth. J. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1 \u03b2 form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/BOR.0000000000000098","article-title":"Biomarkers in systemic juvenile idiopathic arthritis: A comparison with biomarkers in cryopyrin-associated periodic syndromes","volume":"26","author":"Nirmala","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4078\/jrd.2020.27.4.233","article-title":"Role of Biomarkers in Juvenile Idiopathic Arthritis","volume":"27","author":"Ahn","year":"2020","journal-title":"J. Rheum. Dis."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","article-title":"S100A8\/A9 in Inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/JLB.3MIR1218-483RR","article-title":"Below the surface: The inner lives of TLR4 and TLR9","volume":"106","author":"Marongiu","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: From biomarker to biological function","volume":"70","author":"Jukic","year":"2021","journal-title":"Gut"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPG.0000000000000615","article-title":"Faecal calprotectin in suspected paediatric inflammatory bowel disease","volume":"60","author":"Degraeuwe","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41584-018-0058-9","article-title":"S100 Proteins in Rheumatic Diseases","volume":"14","author":"Austermann","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cca.2021.02.022","article-title":"Circulating calprotectin as a biomarker in neutrophil-associated inflammation: Pre-analytical recommendations and reference values depending on the type of sample","volume":"517","author":"Mylemans","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1535370216681551","article-title":"Calprotectin in rheumatic diseases","volume":"242","author":"Ometto","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jbspin.2019.01.003","article-title":"Systemic calprotectin and chronic inflammatory rheumatic diseases","volume":"86","author":"Romand","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Altobelli, E., Angeletti, P.M., Petrocelli, R., Lapergola, G., Farello, G., Cannataro, G., and Breda, L. (2021). Serum Calprotectin a Potential Biomarker in Juvenile Idiopathic Arthritis: A Meta-Analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10214861"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","article-title":"S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin","volume":"58","author":"Wittkowski","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/annrheumdis-2011-200598","article-title":"The Toll-like receptor 4 agonist MRP8\/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis","volume":"71","author":"Holzinger","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/pr.2015.144","article-title":"Comparison of biomarkers for systemic juvenile idiopathic arthritis","volume":"78","author":"Shenoi","year":"2015","journal-title":"Pediatr. Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-020-0398-2","article-title":"The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: A retrospective analysis","volume":"18","author":"Aljaberi","year":"2020","journal-title":"Pediatr. Rheumatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e001646","DOI":"10.1136\/rmdopen-2021-001646","article-title":"Serum calprotectin (S100A8\/A9): A promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis","volume":"7","author":"La","year":"2021","journal-title":"RMD Open"},{"key":"ref_171","first-page":"447","article-title":"Calcium and skeletal metabolism","volume":"123","author":"Deftos","year":"1975","journal-title":"West. J. Med."},{"key":"ref_172","first-page":"1605","article-title":"Procalcitonin increase after endotoxin injection in normal subjects","volume":"79","author":"Dandona","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14787210.2017.1400907","article-title":"Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: A systematic review and meta-analysis","volume":"15","author":"Trippella","year":"2017","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/RHU.0000000000001170","article-title":"Procalcitonin Differs in Children With Infection and Children With Disease Flares in Juvenile Idiopathic Arthritis","volume":"27","author":"Trachtman","year":"2021","journal-title":"J. Clin. Rheumatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2011.07.115","article-title":"Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis","volume":"220","author":"Kim","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.cellsig.2013.06.013","article-title":"Cellular signalling of the receptor for advanced glycation end products (RAGE)","volume":"25","author":"Xie","year":"2013","journal-title":"Cell Signal."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/db12-1528","article-title":"sRAGE and risk of diabetes, cardiovascular disease, and death","volume":"62","author":"Selvin","year":"2013","journal-title":"Diabetes"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12931-021-01686-z","article-title":"Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD","volume":"22","author":"Pratte","year":"2021","journal-title":"Respir. Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/092986706777585013","article-title":"Soluble receptor for advanced glycation end products: From disease marker to potential therapeutic target","volume":"13","author":"Geroldi","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/ATVBAHA.118.312319","article-title":"High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality","volume":"39","author":"Marinkovic","year":"2019","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11010-018-3400-2","article-title":"Is there any evidence that AGE\/sRAGE is a universal biomarker\/risk marker for diseases?","volume":"451","author":"Prasad","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"ref_182","first-page":"2507","article-title":"Soluble receptor for advanced glycation end-products enhanced the production of IFN-\u03b3 through the NF-\u03baB pathway in macrophages recruited by ischemia\/reperfusion","volume":"43","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2119\/2008-00034.Klune","article-title":"HMGB1: Endogenous danger signaling","volume":"14","author":"Klune","year":"2008","journal-title":"Mol. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2011.02430.x","article-title":"Introduction: HMGB1 in inflammation and innate immunity","volume":"270","author":"Andersson","year":"2011","journal-title":"J. Intern. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","article-title":"Targeting Inflammation Driven by HMGB1","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbagrm.2009.11.003","article-title":"The role of HMGB1 in the pathogenesis of rheumatic disease","volume":"1799","author":"Andersson","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2119\/molmed.2013.00164","article-title":"The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases","volume":"20","author":"Magna","year":"2014","journal-title":"Mol. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"172487","DOI":"10.1016\/j.ejphar.2019.172487","article-title":"Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling","volume":"858","author":"Paudel","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/ar1764","article-title":"Soluble RAGE: A hot new biomarker for the hot joint?","volume":"7","author":"Moser","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2119\/molmed.2015.00087","article-title":"High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.1900860","article-title":"Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4","volume":"205","author":"Zhong","year":"2020","journal-title":"J. Immunol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3899\/jrheum.120987","article-title":"HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlated with early onset of disease, and are independent of disease duration","volume":"40","author":"Schierbeck","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1546-0096-12-50","article-title":"The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus","volume":"12","author":"Bobek","year":"2014","journal-title":"Pediatr. Rheumatol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12969-021-00587-1","article-title":"Association between high mobility group box 1 protein and juvenile idiopathic arthritis: A prospective longitudinal study","volume":"19","author":"Xu","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"ref_196","first-page":"782","article-title":"Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis","volume":"25","author":"Wu","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3899\/jrheum.070600","article-title":"Persistent elevation of fibrin d-dimer predicts long term outcome in systemic juvenile idiopathic arthritis","volume":"36","author":"Bloom","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3899\/jrheum.121131","article-title":"Follistatin-like protein 1 and the ferritin\/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"40","author":"Gorelik","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2019-215211","article-title":"Pediatric Rheumatology International Trials Organization, the Childhood Arthritis & Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group and the Histiocyte Society. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"78","author":"Minoia","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/acr2.11048","article-title":"Ferritin to erythrocyte sedimentation rate ratio: Simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"1","author":"Eloseily","year":"2019","journal-title":"ACR Open Rheumatol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12519-019-00256-0","article-title":"Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: A multi-center study in China","volume":"16","author":"Zou","year":"2020","journal-title":"World J. Pediatr."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12969-021-00553-x","article-title":"Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): The potential of serum biomarkers at baseline","volume":"19","author":"Ganeva","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.44.1009","article-title":"Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica","volume":"44","author":"Shimojima","year":"2005","journal-title":"Intern. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3349\/ymj.2012.53.5.1045","article-title":"Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis","volume":"53","author":"Cantarini","year":"2012","journal-title":"Yonsei Med. J."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.51620\/0869-2084-2022-67-1-43-47","article-title":"Analysis of rheumatoid factor and acute phase proteins using microarrays in patients with rheumatoid arthritis","volume":"67","author":"Feyzkhanova","year":"2022","journal-title":"Klin. Lab. Diagn."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"631299","DOI":"10.3389\/fimmu.2020.631299","article-title":"Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker","volume":"11","author":"Kos","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jinf.2020.03.035","article-title":"Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis","volume":"80","author":"Li","year":"2020","journal-title":"J. Infect."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s15010-020-01468-7","article-title":"Prognostic value of serum amyloid A in patients with COVID-19","volume":"48","author":"Cheng","year":"2020","journal-title":"Infection"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4103\/jfmpc.jfmpc_339_19","article-title":"Study of role of serum amyloid A (SAA) as a marker of disease activity in juvenile idiopathic arthritis","volume":"8","author":"Dev","year":"2019","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature12345","article-title":"LRG1 promotes angiogenesis by modulating endothelial TGF-\u03b2 signalling","volume":"499","author":"Wang","year":"2013","journal-title":"Nature"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13075-017-1349-2","article-title":"Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-\u03b2-Smad2 signaling in na\u00efve helper T cells","volume":"19","author":"Urushima","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.118919","article-title":"iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases","volume":"69","author":"Serada","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"8825374","DOI":"10.1155\/2021\/8825374","article-title":"Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease","volume":"2021","author":"Yoshimura","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.2000502","article-title":"The Skin-Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich \u03b1-2 Glycoprotein","volume":"206","author":"Nakajima","year":"2021","journal-title":"J. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Druhan, L.J., Lance, A., Li, S., Price, A.E., Emerson, J.T., Baxter, S.A., Gerber, J.M., and Avalos, B.R. (2017). Leucine Rich \u03b1-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170261"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-022-00790-6","article-title":"LRG1: An emerging player in disease pathogenesis","volume":"29","author":"Camilli","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"809225","DOI":"10.3389\/fphar.2021.809225","article-title":"Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review","volume":"12","author":"Zou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14397595.2016.1270795","article-title":"Leucine-rich \u03b12-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series","volume":"27","author":"Shimizu","year":"2017","journal-title":"Mod. Rheumatol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"3140204","DOI":"10.1155\/2019\/3140204","article-title":"Serum Leucine-Rich \u03b12-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis","volume":"2019","author":"Shimizu","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/annrheumdis-2019-216030","article-title":"Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"79","author":"Lee","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Nakra, N.A., Blumberg, D.A., Herrera-Guerra, A., and Lakshminrusimha, S. (2020). Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children, 7.","DOI":"10.3390\/children7070069"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/S2665-9913(21)00180-6","article-title":"Deciphering the cytokine fingerprint of macrophage activation syndrome","volume":"3","author":"Henderson","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semarthrit.2020.12.007","article-title":"Understanding of cytokines and targeted therapy in macrophage activation syndrome","volume":"51","author":"Tang","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrrheum.2014.208","article-title":"Advances in biomarkers for paediatric rheumatic diseases","volume":"11","author":"Consolaro","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3389\/fimmu.2019.03089","article-title":"Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome","volume":"10","author":"Vandenhaute","year":"2020","journal-title":"Front. Immunol"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Javaux, C., El-Jammal, T., Neau, P.-A., Fournier, N., Gerfaud-Valentin, M., Perard, L., Fouillet-Desjonqueres, M., Le Scanff, J., Vignot, E., and Durupt, S. (2022). Detection and Prediction of Macrophage Activation Syndrome in Still\u2019s Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11010206"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/14397595.2019.1660026","article-title":"The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis","volume":"30","author":"Tanatar","year":"2020","journal-title":"Mod. Rheumatol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","article-title":"Juvenile idiopathic arthritis: From aetiopathogenesis to therapeutic approaches","volume":"19","author":"Zaripova","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"625","DOI":"10.18203\/2349-3291.ijcp20210957","article-title":"Evaluation of serum ferritin and its correlation with disease activity in non-systemic juvenile idiopathic arthritis","volume":"8","author":"Das","year":"2021","journal-title":"Int. J. Contemp. Pediatr."},{"key":"ref_231","first-page":"1784529","article-title":"Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience","volume":"2022","author":"Glerup","year":"2022","journal-title":"Int. J. Rheumatol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/14397595.2020.1761079","article-title":"Treatment of systemic JIA: When do we need a biologic? Real world data of a single center","volume":"31","author":"Acari","year":"2021","journal-title":"Mod. Rheumatol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2018-214354","article-title":"Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes","volume":"78","author":"Lagou","year":"2019","journal-title":"Ann. Rheum. Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/12757\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:01:06Z","timestamp":1760144466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/12757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,22]]},"references-count":233,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232112757"],"URL":"https:\/\/doi.org\/10.3390\/ijms232112757","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,22]]}}}